Mediclinic plunges on weakness in Switzerland and UK

Shares in the private hospital group Mediclinic’s share price fell on Wednesday morning after it released a trading update

AfroCentric consolidates its pharmaceuticals business

AfroCentric has reached an agreement to fully take over drug importer Activo, positioning itself to compete with pharmaceutical giants

AfroCentric plunges after announcing call option

AfroCentric's principal subsidiary is medical scheme company Medscheme

Paint that wards off mosquitoes launched in Zambia

Zambia aims to eradicate malaria, the country’s biggest killer, within three years

US stops imports from China's Zhejiang Huahai after heart drug recall

The Chinese maker of valsartan recalled the product from consumers in the US in July because an impurity linked to cancer had been detected

Life Healthcare expects better patient numbers to lift full-year revenue

The private hospital group’s European operations outperform its SA unit

Oxford experts and J&J get $19m to create vaccines against three deadly viruses

The Janssen vaccines unit and specialists at the Jenner Institute were involved in developing an Ebola vaccine in 2014, and the hope is that some of that ...

Netcare shares slide after gloomy update

Private hospital group says earnings for the year to September 30 would fall slightly compared with the year before

WATCH: How acquisitions improved the health of Ascendis

Ascendis Health CEO Thomas Thomsen talks to Business Day TV about the group’s full-year results

Debt-laden Ascendis Health plans to dispose of bioscience unit

Ascendis has already sold its sports nutrition business in SA and its direct-selling unit

Novartis to cut 2,550 jobs in Switzerland and UK to boost profit

The Swiss drugmaker's restructuring comes as part of a programme announced in 2016 to save about $1bn annually

Ascendis reports healthier margins after recent acquisitions

Revenue climbs 21% to R7.7bn in the year to end-August, boosted by its acquisitions of higher margin businesses

Soaring Weight Watchers trims itself down to WW

The company’s shares have gained nearly 60% this year, after surging almost 300% in 2017

Life Healthcare finally exits its Indian business

Stake in Max Healthcare finally to be sold to investment firm Kohlberg Kravis Roberts after tepid returns

Shares keep falling even though Aspen spells out details of business

Aspen announced last week that it would sell its baby-formula unit at a price the market perceived to be too low

Come 2019, this is how much more your medical scheme will cost you

Discovery Health CEO Jonathan Broomberg says the scheme’s administrator estimates total medical inflation for 2018 at between 11.2% and 12.2%

Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.